How NOD2 mutations predispose to Crohn's disease?

Microbes and Infection

Volumn 9, Issue 5, 2007, Pages 658-663

  Vignal, Cecile ^a,b,c   Singer, Elisabeth ^b   Peyrin Biroulet, Laurent ^a,b,c   Desreumaux, Pierre ^a,b,c   Chamaillard, Mathias ^a,b,c  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Crohn's disease; Innate and adaptive immunity; Intestinal inflammation; Intestinal tolerance; Nucleotide binding oligomerisation domain protein 2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE; CYTOKINE; MURAMYL DIPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT;

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; ANTIMICROBIAL ACTIVITY; COLITIS; COLON CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; ENTERITIS; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; INTESTINE INFECTION; MUTANT; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; REGULATORY MECHANISM; SHORT SURVEY;

CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNITY, NATURAL; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; SYNDROME;

BACTERIA (MICROORGANISMS); MUS;

EID: 34247116430     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.01.016     Document Type: Short Survey

References (47)

1. Chamaillard M., Philpott D., Girardin S.E., Zouali H., Lesage S., Chareyre F., Bui T.H., Giovannini M., Zaehringer U., Penard-Lacronique V., Sansonetti P.J., Hugot J.P., and Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. U.SA. 100 (2003) 3455-3460
2. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., and Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278 (2003) 5509-5512
3. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., and Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278 (2003) 8869-8872
4. Inohara N., Chamaillard M., McDonald C., and Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74 (2005) 355-383
5. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
6. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
7. Miceli-Richard C., Lesage S., Rybojad M., Prieur A.M., Manouvrier-Hanu S., Hafner R., Chamaillard M., Zouali H., Thomas G., and Hugot J.P. CARD15 mutations in Blau syndrome. Nat. Genet. 29 (2001) 19-20
8. Kanazawa N., Okafuji I., Kambe N., Nishikomori R., Nakata-Hizume M., Nagai S., Fuji A., Yuasa T., Manki A., Sakurai Y., Nakajima M., Kobayashi H., Fujiwara I., Tsutsumi H., Utani A., Nishigori C., Heike T., Nakahata T., and Miyachi Y. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105 (2005) 1195-1197
9. Pauleau A.L., and Murray P.J. Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol. Cell. Biol. 23 (2003) 7531-7539
10. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., and Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
11. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., Eckmann L., and Karin M. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
12. Magalhaes J.G., Philpott D.J., Nahori M.A., Jehanno M., Fritz J., Bourhis L.L., Viala J., Hugot J.P., Giovannini M., Bertin J., Lepoivre M., Mengin-Lecreulx D., Sansonetti P.J., and Girardin S.E. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. (2005)
13. Watanabe T., Kitani A., Murray P.J., and Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5 (2004) 800-808
14. Inohara N., Koseki T., Lin J., del Peso L., Lucas P.C., Chen F.F., Ogura Y., and Nunez G. An induced proximity model for NF-kappaB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275 (2000) 27823-27831
15. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., and Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276 (2001) 4812-4818
16. Abbott D.W., Wilkins A., Asara J.M., and Cantley L.C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14 (2004) 2217-2227
17. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., and Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416 (2002) 194-199
18. Chen C.M., Gong Y., Zhang M., and Chen J.J. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279 (2004) 25876-25882
19. Barnich N., Hisamatsu T., Aguirre J.E., Xavier R., Reinecker H.C., and Podolsky D.K. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J. Biol. Chem. 280 (2005) 19021-19026
20. Yamamoto-Furusho J.K., Barnich N., Xavier R., Hisamatsu T., and Podolsky D.K. Centaurin Beta 1 down-regulates NOD1 and NOD2-dependent NF-kB activation. J. Biol. Chem. (2006)
21. McDonald C., Chen F.F., Ollendorff V., Ogura Y., Marchetto S., Lecine P., Borg J.P., and Nunez G. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. J. Biol. Chem. 280 (2005) 40301-40309
22. Tanabe T., Chamaillard M., Ogura Y., Zhu L., Qiu S., Masumoto J., Ghosh P., Moran A., Predergast M.M., Tromp G., Williams C.J., Inohara N., and Nunez G. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23 (2004) 1587-1597
23. Bonen D.K., and Cho J.H. The genetics of inflammatory bowel disease. Gastroenterol. 124 (2003) 521-536
24. Li J., Moran T., Swanson E., Julian C., Harris J., Bonen D.K., Hedl M., Nicolae D.L., Abraham C., and Cho J.H. Regulation of IL-8 and IL-1{beta} expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13 (2004) 1715-1725
25. van Heel D.A., Ghosh S., Butler M., Hunt K.A., Lundberg A.M., Ahmad T., McGovern D.P., Onnie C., Negoro K., Goldthorpe S., Foxwell B.M., Mathew C.G., Forbes A., Jewell D.P., and Playford R.J. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365 (2005) 1794-1796
26. Orholm M., Iselius L., Sorensen T.I., Munkholm P., Langholz E., and Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ 306 (1993) 20-24
27. Monsen U. Inflammatory bowel disease. An epidemiological and genetic study. Acta Chir. Scand. Suppl. 559 (1990) 1-42
28. Kuster W., Pascoe L., Purrmann J., Funk S., and Majewski F. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am. J. Med. Genet. 32 (1989) 105-108
29. Netea M.G., Ferwerda G., de Jong D.J., Jansen T., Jacobs L., Kramer M., Naber T.H., Drenth J.P., Girardin S.E., Kullberg B.J., Adema G.J., and Van der Meer J.W. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 174 (2005) 6518-6523
30. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., and Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004) 213-218
31. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., and Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20 (2004) 319-325
32. Peyrin-Biroulet L., Vignal C., Dessein R., Simonet M., Desreumaux P., and Chamaillard M. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol. (2006)
33. Ganz T. Paneth cells-guardians of the gut cell hatchery. Nat. Immunol. 1 (2000) 99-100
34. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schaffeler E., Schlee M., Herrlinger K.R., Stallmach A., Noack F., Fritz P., Schroder J.M., Bevins C.L., Fellermann K., and Stange E.F. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53 (2004) 1658-1664
35. Ayabe H., Tanabe T., Kono T., Ito T., Maemoto A., Watari J., Ashida T., Ouellette A.J., and Kohgo Y. The innate intestinal immunity by Paneth cells and their alpha-defensins in patients with Crohn's disease. Gastroenterol. 128 (2005) TI546
36. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18129-18134
37. Rumio C., Besusso D., Palazzo M., Selleri S., Sfondrini L., Dubini F., Menard S., and Balsari A. Degranulation of paneth cells via toll-like receptor 9. Am. J. Pathol. 165 (2004) 373-381
38. Watanabe T., Kitani A., Murray P.J., Wakatsuki Y., Fuss I.J., and Strober W. Nucleotide binding oligomerisation domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 25 (2006) 473-485
39. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., and Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006)
40. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D.J., Kastelein R.A., and Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116 (2006) 1310-1316
41. Becker C., Dornhoff H., Neufert C., Fantini M.C., Wirtz S., Huebner S., Nikolaev A., Lehr H.A., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Galle P.R., Karow M., and Neurath M.F. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 177 (2006) 2760-2764
42. Waters C.M., and Bassler B.L. QUORUM SENSING: cell-to-cell communication in bacteria. Annu. Rev. Cell. Dev. Biol. 21 (2005) 319-346
43. Chacon O., Bermudez L.E., and Barletta R.G. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58 (2004) 329-363
44. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., Di Martino P., Desreumaux P., Gambiez L., Joly B., Cortot A., and Colombel J.F. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterol. 115 (1998) 1405-1413
45. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., Fort M., and Hershberg R.M. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 113 (2004) 1296-1306
46. Liu Y., van Kruiningen H.J., West A.B., Cartun R.W., Cortot A., and Colombel J.F. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterol. 108 (1995) 1396-1404
47. Brown W.R. Listeria: the latest putative pathogenetic microorganism in Crohn's disease. Gastroenterol. 108 (1995) 1589-1590